Atlas Trials

Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita

Clinical trial NCT01001598 · TERMINATED

Trial details

NCT number
NCT01001598
Sponsor
Boston Children's Hospital
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Fanconi AnemiaDyskeratosis Congenita
Start date
2009-11-01
Primary completion
2014-05-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.